BIOMAT Database Logo BIOMAT Database Logo

The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy. 1991

T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Japan.

The hypercoagulable state in patients with toxemia of pregnancy was investigated in comparison with normal pregnant women using new coagulation parameters, mainly thrombin-antithrombin III (TAT) complexes, alpha 2-antiplasmin-plasmin complexes (PIP), and D-dimer FDP. When the patients were categorized by the classification of the WHO Study Group (1985), significant increases of TAT complexes and alpha 2-PIP complexes with decreases of the ATIII level were observed in the groups with preeclampsia and severe gestational hypertensive disease as compared to normal pregnant women. A significant increase of D-dimer FDP was observed in a group with severe gestational hypertensive disease. Additionally, the relationship between clinical signs and the hypercoagulable state in the patients was analyzed using canonical correlation analysis as a multivariate analysis. The clinical signs and coagulation parameters had a significantly high correlation of lambda 1 = 0.7219, p less than 0.01. The results showed that clinical signs were associated with simultaneous coagulation abnormalities. The indices obtained from the results of canonical correlation analysis, which were called the clinical index and the coagulation index, should be useful in evaluating the efficacy of anticoagulation therapy.

UI MeSH Term Description Entries
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
Toxemia of pregnancy: relationship between fetal weight, fetal survival, and the maternal state.
January 1971, American journal of obstetrics and gynecology,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
[The relationship between ophthalmoscopic changes and classification of toxemia in toxemia of pregnancy].
September 1990, Nippon Ganka Gakkai zasshi,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
The convulsive state of pregnancy toxemia.
November 1960, The Journal of the American Osteopathic Association,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
The hypercoagulable state in clinical practice.
October 1991, British journal of haematology,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
[Experimental studies on toxemia of pregnancy: relationship between sodium chloride and hypertension in pregnancy].
August 1984, Nihon Sanka Fujinka Gakkai zasshi,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
[Progress in relationship between heritable hypercoagulable state and avascular necrosis of femoral head].
June 2012, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
[Neuro-endocrine relationship in pregnancy toxemia].
September 1955, Orvosi hetilap,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
Toxemia of pregnancy: production of lesions in the absence of signs.
June 1966, American journal of obstetrics and gynecology,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
[Retinochoroidopathy and systemic state in toxemia of pregnancy].
October 1991, Nippon Ganka Gakkai zasshi,
T Terao, and M Maki, and T Ikenoue, and K Gotoh, and M Murata, and H Iwasaki, and J Shibata, and M Nakabayashi, and M Muraoka, and Y Takeda
[HYPERCOAGULABLE STATE AND ITS CLINICAL ASPECTS].
March 1964, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
Copied contents to your clipboard!